Balanced news tone
News Sentiment
IDIA sentiment intelligence
Idorsia Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
23 relevant articles
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+25.1% over one week, +37.3% over four weeks, trend active, and materially above fair value.
Idorsia (SWX:IDIA) Valuation After CHF 250 Million Term Loan Reshapes Debt And Liquidity
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
85/100 classification
One-week reaction
25.1%
Price confirming higher
Trend fit
Trend active
37.3% over four weeks
Fair value
116.5%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
17
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
Idorsia (SWX:IDIA) Valuation After CHF 250 Million Term Loan Reshapes Debt And Liquidity
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 09 Jun 2026 07:00
- Source
- simplywall.st
marketscreener.com
Direct company coverage
Idorsia Catches Its Breath, Trigano Stalls
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Idorsia Ltd Strengthens Financial Position with Up to CHF 250 Million Loan from Pharmakon Advisors, LP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Idorsia Ltd announced that it expects to receive CHF 250 million in funding
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 08 Jun 2026 22:00
- Source
- marketscreener.com
Market source
Direct company coverage
Is It Too Late To Consider Idorsia (SWX:IDIA) After Its Sharp 1-Year Surge
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
How The Idorsia (SWX:IDIA) Story Is Shifting As Price Targets And Risks Reset
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Why The Idorsia (SWX:IDIA) Narrative Is Resetting As Price Targets And Risks Evolve
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 20 Mar 2026 07:00
- Source
- Market source
SWI swissinfo.ch
Direct company coverage
Swiss pharma firm Idorsia CEO resigns after less than a year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- SWI swissinfo.ch
simplywall.st
Direct company coverage
Does Idorsia’s Latin America QUVIVIQ Deal and Lucerastat Data Change The Bull Case For Idorsia (SWX:IDIA)?
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 04 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Latin America QUVIVIQ Deal Could Be A Game Changer For Idorsia (SWX:IDIA)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Idorsia’s daridorexant in women during menopausal transition age with insomnia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jan 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Idorsia Ltd (VTX:IDIA) Surges 28% Yet Its Low P/S Is No Reason For Excitement
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Dec 2025 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Sep 2025 07:00
- Source
- Market source
Investing.com
Direct company coverage
Idorsia H1 2025 presentation: QUVIVIQ sales surge, profitability horizon in sight
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jul 2025 07:00
- Source
- Investing.com
Pharmaceutical Technology
Direct company coverage
Idorsia’s Tryvio deal collapses, forcing company to find cash urgently
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Feb 2025 08:00
- Source
- Pharmaceutical Technology
BioWorld News
Direct company coverage
J&J ‘mistake’? Idorsia’s Tryvio wins FDA nod in hypertension
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Mar 2024 07:00
- Source
- BioWorld News
Fierce Biotech
Direct company coverage
J&J hands back $230M blood pressure drug to Idorsia with approval in sight
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 06 Sep 2023 07:00
- Source
- Fierce Biotech
Fierce Biotech
Direct company coverage
Idorsia's Fabry med did what executives were expecting—it just didn't relieve the disease's hallmark burning pain
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Oct 2021 07:00
- Source
- Fierce Biotech
Reuters
Direct company coverage
Idorsia Ltd
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2021 05:34
- Source
- Reuters
marketscreener.com
Direct company coverage
Idorsia Ltd: Target Price Consensus and Analysts Recommendations | IDIA | CH0363463438
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Aug 2020 17:33
- Source
- marketscreener.com
Labiotech.eu
Direct company coverage
How is Actelion Spin-Off Idorsia Doing One Year Later?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Mar 2018 08:00
- Source
- Labiotech.eu
TradingView
Direct company coverage
Technical Analysis of Idorsia Ltd. (SIX:IDIA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Jan 2018 21:54
- Source
- TradingView
Fierce Biotech
Direct company coverage
Idorsia spins out of Johnson & Johnson-Actelion with $1B and multidrug pipeline, sees shares jump 30% on first day of trading
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2017 07:00
- Source
- Fierce Biotech